292 related articles for article (PubMed ID: 32315618)
1. Selective PP2A Enhancement through Biased Heterotrimer Stabilization.
Leonard D; Huang W; Izadmehr S; O'Connor CM; Wiredja DD; Wang Z; Zaware N; Chen Y; Schlatzer DM; Kiselar J; Vasireddi N; Schüchner S; Perl AL; Galsky MD; Xu W; Brautigan DL; Ogris E; Taylor DJ; Narla G
Cell; 2020 Apr; 181(3):688-701.e16. PubMed ID: 32315618
[TBL] [Abstract][Full Text] [Related]
2. Select Stabilization of a Tumor-Suppressive PP2A Heterotrimer.
Shah VM; English IA; Sears RC
Trends Pharmacol Sci; 2020 Sep; 41(9):595-597. PubMed ID: 32624198
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
[TBL] [Abstract][Full Text] [Related]
4. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
[TBL] [Abstract][Full Text] [Related]
5. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail).
Janssens V; Longin S; Goris J
Trends Biochem Sci; 2008 Mar; 33(3):113-21. PubMed ID: 18291659
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.
Morita K; He S; Nowak RP; Wang J; Zimmerman MW; Fu C; Durbin AD; Martel MW; Prutsch N; Gray NS; Fischer ES; Look AT
Cell; 2020 Apr; 181(3):702-715.e20. PubMed ID: 32315619
[TBL] [Abstract][Full Text] [Related]
7. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.
Haanen TJ; O'Connor CM; Narla G
J Biol Chem; 2022 Dec; 298(12):102656. PubMed ID: 36328247
[TBL] [Abstract][Full Text] [Related]
8. Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.
Kwun HJ; Shuda M; Camacho CJ; Gamper AM; Thant M; Chang Y; Moore PS
J Virol; 2015 Apr; 89(8):4191-200. PubMed ID: 25631078
[TBL] [Abstract][Full Text] [Related]
9. Identification of PP2A complexes and pathways involved in cell transformation.
Sablina AA; Hector M; Colpaert N; Hahn WC
Cancer Res; 2010 Dec; 70(24):10474-84. PubMed ID: 21159657
[TBL] [Abstract][Full Text] [Related]
10. Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.
Sangodkar J; Perl A; Tohme R; Kiselar J; Kastrinsky DB; Zaware N; Izadmehr S; Mazhar S; Wiredja DD; O'Connor CM; Hoon D; Dhawan NS; Schlatzer D; Yao S; Leonard D; Borczuk AC; Gokulrangan G; Wang L; Svenson E; Farrington CC; Yuan E; Avelar RA; Stachnik A; Smith B; Gidwani V; Giannini HM; McQuaid D; McClinch K; Wang Z; Levine AC; Sears RC; Chen EY; Duan Q; Datt M; Haider S; Ma'ayan A; DiFeo A; Sharma N; Galsky MD; Brautigan DL; Ioannou YA; Xu W; Chance MR; Ohlmeyer M; Narla G
J Clin Invest; 2017 Jun; 127(6):2081-2090. PubMed ID: 28504649
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 2A regulatory subunit B56α limits phosphatase activity in the heart.
Little SC; Curran J; Makara MA; Kline CF; Ho HT; Xu Z; Wu X; Polina I; Musa H; Meadows AM; Carnes CA; Biesiadecki BJ; Davis JP; Weisleder N; Györke S; Wehrens XH; Hund TJ; Mohler PJ
Sci Signal; 2015 Jul; 8(386):ra72. PubMed ID: 26198358
[TBL] [Abstract][Full Text] [Related]
12. Structural mechanism of demethylation and inactivation of protein phosphatase 2A.
Xing Y; Li Z; Chen Y; Stock JB; Jeffrey PD; Shi Y
Cell; 2008 Apr; 133(1):154-63. PubMed ID: 18394995
[TBL] [Abstract][Full Text] [Related]
13. Assembly and structure of protein phosphatase 2A.
Shi Y
Sci China C Life Sci; 2009 Feb; 52(2):135-46. PubMed ID: 19277525
[TBL] [Abstract][Full Text] [Related]
14. A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.
Goudreault M; D'Ambrosio LM; Kean MJ; Mullin MJ; Larsen BG; Sanchez A; Chaudhry S; Chen GI; Sicheri F; Nesvizhskii AI; Aebersold R; Raught B; Gingras AC
Mol Cell Proteomics; 2009 Jan; 8(1):157-71. PubMed ID: 18782753
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56α subunit.
Kawashima I; Kirito K
Exp Hematol; 2016 Dec; 44(12):1156-1165.e4. PubMed ID: 27576133
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model.
Janghorban M; Langer EM; Wang X; Zachman D; Daniel CJ; Hooper J; Fleming WH; Agarwal A; Sears RC
PLoS One; 2017; 12(11):e0188910. PubMed ID: 29190822
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d.
Joseph BK; Liu HY; Francisco J; Pandya D; Donigan M; Gallo-Ebert C; Giordano C; Bata A; Nickels JT
J Biol Chem; 2015 Apr; 290(17):10588-98. PubMed ID: 25694423
[TBL] [Abstract][Full Text] [Related]
18. A critical role for the protein phosphatase 2A B'α regulatory subunit in dephosphorylation of sphingosine kinase 1.
Pitman MR; Barr RK; Gliddon BL; Magarey AM; Moretti PA; Pitson SM
Int J Biochem Cell Biol; 2011 Mar; 43(3):342-7. PubMed ID: 21075214
[TBL] [Abstract][Full Text] [Related]
19. PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer.
Fowle H; Zhao Z; Graña X
Adv Cancer Res; 2019; 144():55-93. PubMed ID: 31349904
[TBL] [Abstract][Full Text] [Related]
20. Antibodies recognizing the C terminus of PP2A catalytic subunit are unsuitable for evaluating PP2A activity and holoenzyme composition.
Frohner IE; Mudrak I; Kronlachner S; Schüchner S; Ogris E
Sci Signal; 2020 Jan; 13(616):. PubMed ID: 31992581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
